ISIN | LU1589327680 |
---|---|
Valor Number | 36494209 |
Bloomberg Global ID | EURCHA SW |
Fund Name | UBS (Lux) Fund Solutions – UBS Core MSCI Europe UCITS ETF hCHF acc |
Fund Provider |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Asset Management Switzerland AG, Zurich |
Representative in Switzerland |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Distributor(s) |
UBS AG Basel Phone: +41 61 288 20 20 UBS AG, Zürich Zürich Phone: +41 44 234 11 11 |
Asset Class | Equities |
EFC Category | Equity Advanced Europe |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The sub-fund aims to track, before expenses, the price and income performance of the MSCI Europe Index (Net Return) (this sub-fund's "Index"). |
Peculiarities |
Current Price * | 4.48 CHF | 27.06.2025 |
---|---|---|
Previous Price * | 4.43 CHF | 26.06.2025 |
52 Week High * | 4.57 CHF | 03.03.2025 |
52 Week Low * | 3.87 CHF | 09.04.2025 |
NAV * | 4.48 CHF | 27.06.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 513,753,370 | |
Unit/Share Assets *** | 60,554,743 | |
Trading Information SIX |
YTD Performance | +8.76% |
31.12.2024 - 27.06.2025
31.12.2024 27.06.2025 |
---|---|---|
1 month | -1.14% |
27.05.2025 - 27.06.2025
27.05.2025 27.06.2025 |
3 months | +0.89% |
27.03.2025 - 27.06.2025
27.03.2025 27.06.2025 |
6 months | +8.72% |
27.12.2024 - 27.06.2025
27.12.2024 27.06.2025 |
1 year | +5.73% |
27.06.2024 - 27.06.2025
27.06.2024 27.06.2025 |
2 years | +19.16% |
27.06.2023 - 27.06.2025
27.06.2023 27.06.2025 |
3 years | +32.69% |
27.06.2022 - 27.06.2025
27.06.2022 27.06.2025 |
5 years | +57.76% |
29.06.2020 - 27.06.2025
29.06.2020 27.06.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
ASML Holding NV | 2.59% | |
---|---|---|
SAP SE | 2.49% | |
Nestle SA | 2.11% | |
Roche Holding AG | 1.84% | |
Novartis AG Registered Shares | 1.83% | |
Novo Nordisk AS Class B | 1.78% | |
AstraZeneca PLC | 1.76% | |
HSBC Holdings PLC | 1.74% | |
Shell PLC | 1.70% | |
Siemens AG | 1.54% | |
Last data update | 25.06.2025 |
TER | 0.13% |
---|---|
TER date | 30.06.2024 |
Performance Fee *** | 0.00% |
PTR | |
Max. Management Fee *** | 0.09% |
Ongoing Charges *** | 0.09% |
SRRI ***
|
|
SRRI date *** | 31.05.2025 |